# Method of Oxygen Delivery and the Effect on Transcutaneous PaCO2

> **NCT00135252** · PHASE2,PHASE3 · TERMINATED · sponsor: **The University of Texas Health Science Center, Houston** · enrollment: 44 (estimated)

## Conditions studied

- Lung Diseases, Obstructive

## Interventions

- **PROCEDURE:** nasal cannula oxygen delivery
- **PROCEDURE:** supplemental oxygen delivery by hood

## Key facts

- **NCT ID:** NCT00135252
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-08
- **Primary completion:** —
- **Final completion:** 2006-06
- **Target enrollment:** 44 (ESTIMATED)
- **Why stopped:** Investigator left institution
- **Last updated:** 2008-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00135252

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00135252, "Method of Oxygen Delivery and the Effect on Transcutaneous PaCO2". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00135252. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*